Board Certified Podiatrists | Expert Foot & Ankle Care
(810) 206-1402 Patient Portal

Raynaud’s Phenomenon in the Feet: Cold-Induced Vasospasm, Diagnosis, and Management

Quick answer: Raynauds Phenomenon Feet Cold Vasospasm is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Hills practices. Call (810) 206-1402.

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Medically Reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatrist, Balance Foot & Ankle Specialists, Michigan. Last updated April 2026.

Dr. Tom explains foot care for patients with complex medical conditions.

What Is Raynaud’s Phenomenon?

Raynaud’s phenomenon is an episodic vasospastic disorder affecting the digital arteries — the small blood vessels supplying the fingers and toes — characterized by a triphasic color change in response to cold exposure or emotional stress. The classic sequence involves: pallor (white) as vasospasm occludes digital arterial blood flow; cyanosis (blue/purple) as deoxygenated blood accumulates in the ischemic digits; and rubor (red) as reactive hyperemia follows vasospasm release and blood rushes back into the reperfusing digits. Accompanying sensations include numbness and tingling during the ischemic phase and burning pain or throbbing during reperfusion.

Raynaud’s phenomenon affects an estimated 3–5% of the general population in the United States, with significantly higher prevalence in cold climates — including Michigan, where cold winters create frequent cold-exposure triggers. While it is most recognized in the hands, toe involvement is equally common and in some patients more prominent, particularly affecting the great toe and lesser toes during cold-weather ambulation.

Primary vs. Secondary Raynaud’s

Primary Raynaud’s Disease

Primary Raynaud’s — also called Raynaud’s disease — occurs without an identifiable underlying cause. It is the most common form, affecting predominantly young women between ages 15–30. The vasospastic episodes are typically milder, less prolonged, and do not produce digital ulceration or tissue injury. There is no associated connective tissue disease, and laboratory evaluation is normal including negative ANA. Primary Raynaud’s is generally benign — it causes significant inconvenience and discomfort but rarely produces permanent tissue damage. It may improve or resolve over years in some patients.

Secondary Raynaud’s Phenomenon

Secondary Raynaud’s occurs in the context of an underlying condition — most commonly connective tissue diseases. The most important underlying associations include systemic sclerosis (scleroderma) — where Raynaud’s is present in over 95% of patients and is often the first manifestation, preceding other features by years; lupus erythematosus; Sjögren’s syndrome; mixed connective tissue disease; rheumatoid arthritis; and inflammatory myopathy. Other causes include occupational vibration exposure (vibration white finger in jackhammer operators), thoracic outlet syndrome, medications (beta-blockers, ergotamines, chemotherapy agents), cryoglobulinemia, and hypothyroidism.

Secondary Raynaud’s is generally more severe than primary, with longer-duration episodes, asymmetric involvement (different digits affected differently), and — critically — risk of digital ulceration and gangrene in severe cases. Distinguishing primary from secondary Raynaud’s is essential because secondary requires treatment of the underlying disease in addition to vasospasm management.

Diagnostic Evaluation

The clinical history and physical examination establish the diagnosis in most cases. Key discriminating features favoring secondary Raynaud’s include: onset after age 30, asymmetric or severe attacks, digital ulceration, positive ANA or other autoimmune serologies, digital pitting scars, capillaroscopy abnormalities (nail fold capillaroscopy showing dilated or absent capillary loops characteristic of scleroderma), or any systemic symptoms (joint pain, dry eyes/mouth, skin thickening).

Laboratory evaluation for secondary Raynaud’s includes: CBC, complete metabolic panel, thyroid function tests, ESR, CRP, ANA with reflex antibody testing (anti-Scl-70, anti-centromere, anti-dsDNA, anti-Ro/La), cryoglobulins, and cold agglutinins. Doppler arterial studies of the feet may identify proximal arterial disease contributing to digital ischemia.

Toe-Specific Manifestations

Raynaud’s in the toes produces the same triphasic color changes as in the fingers, but with some important clinical differences. Cold-weather walking — particularly in Michigan from October through April — is a potent trigger, as the combination of ambient cold, ground-conducted cold through footwear soles, and reduced perfusion from dependent position maximizes vasospastic tendency. Socks and shoes provide more continuous cold exposure than intermittent hand exposure to cold objects.

In secondary Raynaud’s, toe digital ulceration — painful, necrotic lesions at the tips or lateral borders of the toes — is the most feared complication. Digital ulcers in the toes heal poorly because of their distal location in the vascular tree and the mechanical stresses of weight-bearing. They frequently become infected; in patients with underlying systemic sclerosis and compromised digital perfusion, toe ulcers can progress to gangrene requiring amputation.

Conservative Management

Behavioral cold avoidance is the foundation of Raynaud’s management. Keep the entire body warm — vasospasm in the toes can be triggered by core body cooling even without direct toe cold exposure. Wear insulated, moisture-wicking socks; multiple thin sock layers trap more air (insulation) than a single thick sock. Heated insoles are useful for patients with severe cold sensitivity during winter activity. Chemical hand and foot warmers — activated when needed — provide localized warming. Smoking cessation is essential — nicotine is a potent vasoconstrictor that substantially worsens Raynaud’s. Stress management reduces sympathetic-mediated vasospasm.

Pharmacological Treatment

When behavioral measures are insufficient, pharmacological treatment is indicated — particularly for secondary Raynaud’s with digital ulceration or functionally disabling attacks. Calcium channel blockers — particularly long-acting dihydropyridines (nifedipine, amlodipine) — are first-line. They relax vascular smooth muscle, reducing the frequency and severity of vasospastic episodes. Phosphodiesterase-5 inhibitors (sildenafil, tadalafil) are highly effective for severe secondary Raynaud’s and active digital ulcers, improving digital blood flow through cGMP-mediated vasodilation. Alpha-1 blockers (prazosin, doxazosin) and topical nitroglycerin applied to the base of the affected digits are alternative options.

Wound Care for Raynaud’s Digital Ulcers

Active digital ulcers in toes require specialist wound care. Moist wound healing with appropriate dressings, infection management with targeted antibiotics when indicated, and offloading of mechanical pressure from footwear are all essential. Iloprost (a prostacyclin analog administered intravenously) is used in severe cases with non-healing ulcers or critical digital ischemia. Digital sympathectomy — surgical disruption of the sympathetic nerve fibers supplying the digital arteries — is a last-resort option for refractory digital ulcers that fail medical management. Any patient with Raynaud’s who develops toe color changes that do not resolve with warming within 15 minutes, toe skin breakdown, or persistent toe pain should seek prompt evaluation.

Relief Starts With One Appointment

Board-certified podiatrists serving Southeast Michigan — same-week appointments available.

Book Your Appointment

Raynaud’s & Circulation Treatment in Michigan

Raynaud’s phenomenon causes painful color changes and numbness in the toes from cold-induced vasospasm. Dr. Tom Biernacki provides vascular assessment, circulation treatment, and management strategies for Raynaud’s affecting the feet at Balance Foot & Ankle.

Learn About Our Circulation Treatments | Book Your Appointment | Call (810) 206-1402

Clinical References

  1. Herrick AL. “The pathogenesis, diagnosis, and treatment of Raynaud phenomenon.” Nat Rev Rheumatol. 2012;8(8):469-479.
  2. Wigley FM. “Raynaud’s phenomenon.” N Engl J Med. 2002;347(13):1001-1008.
  3. Pope JE. “The diagnosis and treatment of Raynaud’s phenomenon.” Drugs. 2007;67(4):517-525.

Insurance Accepted

BCBS · Medicare · Aetna · Cigna · United Healthcare · HAP · Priority Health · Humana · View All →

Ready to Get Back on Your Feet?

Same-week appointments available at both locations.

Book Your Appointment

(810) 206-1402

Watch: Raynaud’s Phenomenon in the Feet

Dr. Tom on Raynaud’s feet — cold-induced vasospasm (white-blue-red triad), primary vs secondary (autoimmune), avoidance strategies, thermal insoles, calcium-channel blocker role, ulcer risk.

Book Same-Week Appointment · (810) 206-1402

Cold-Foot Kit

Thermal protection. Dr. Tom’s kit:

As an Amazon Associate, Balance Foot & Ankle earns from qualifying purchases. This supports our free patient education content.

Thermal Insoles →

Daily warmth.

NervaCore B-Complex →

Circulation/neuropathy adjunct.

Doctor Hoy’s Pain Gel →

Topical warming comfort.

Compression Support →

Circulation support.

Related: Neuropathy Care · Vascular Caution · Book Raynaud’s Eval

Book Same-Week Appointment →

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your foot and ankle conditions, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.

★★★★★ 4.9 Stars · 1,123+ Five-Star Reviews

Get Expert Care at Balance Foot & Ankle

Same-week appointments at our Howell and Bloomfield Hills offices. Board-certified podiatric surgeons. Most insurance accepted.

Balance Foot & Ankle surgeons are affiliated with Trinity Health Michigan, Corewell Health, and Henry Ford Health — three of Michigan’s largest health systems.